Healthcare Global Enterprises Ltd
NSE:HCG

Watchlist Manager
Healthcare Global Enterprises Ltd Logo
Healthcare Global Enterprises Ltd
NSE:HCG
Watchlist
Price: 468.3 INR -0.04% Market Closed
Market Cap: 65.3B INR
Have any thoughts about
Healthcare Global Enterprises Ltd?
Write Note

Intrinsic Value

The intrinsic value of one HCG stock under the Base Case scenario is 492.71 INR. Compared to the current market price of 468.3 INR, Healthcare Global Enterprises Ltd is Undervalued by 5%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HCG Intrinsic Value
492.71 INR
Undervaluation 5%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Healthcare Global Enterprises Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for HCG cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about HCG?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Healthcare Global Enterprises Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Healthcare Global Enterprises Ltd

Provide an overview of the primary business activities
of Healthcare Global Enterprises Ltd.

What unique competitive advantages
does Healthcare Global Enterprises Ltd hold over its rivals?

What risks and challenges
does Healthcare Global Enterprises Ltd face in the near future?

Has there been any significant insider trading activity
in Healthcare Global Enterprises Ltd recently?

Summarize the latest earnings call
of Healthcare Global Enterprises Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Healthcare Global Enterprises Ltd.

Provide P/S
for Healthcare Global Enterprises Ltd.

Provide P/E
for Healthcare Global Enterprises Ltd.

Provide P/OCF
for Healthcare Global Enterprises Ltd.

Provide P/FCFE
for Healthcare Global Enterprises Ltd.

Provide P/B
for Healthcare Global Enterprises Ltd.

Provide EV/S
for Healthcare Global Enterprises Ltd.

Provide EV/GP
for Healthcare Global Enterprises Ltd.

Provide EV/EBITDA
for Healthcare Global Enterprises Ltd.

Provide EV/EBIT
for Healthcare Global Enterprises Ltd.

Provide EV/OCF
for Healthcare Global Enterprises Ltd.

Provide EV/FCFF
for Healthcare Global Enterprises Ltd.

Provide EV/IC
for Healthcare Global Enterprises Ltd.

Show me price targets
for Healthcare Global Enterprises Ltd made by professional analysts.

What are the Revenue projections
for Healthcare Global Enterprises Ltd?

How accurate were the past Revenue estimates
for Healthcare Global Enterprises Ltd?

What are the Net Income projections
for Healthcare Global Enterprises Ltd?

How accurate were the past Net Income estimates
for Healthcare Global Enterprises Ltd?

What are the EPS projections
for Healthcare Global Enterprises Ltd?

How accurate were the past EPS estimates
for Healthcare Global Enterprises Ltd?

What are the EBIT projections
for Healthcare Global Enterprises Ltd?

How accurate were the past EBIT estimates
for Healthcare Global Enterprises Ltd?

Compare the revenue forecasts
for Healthcare Global Enterprises Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Healthcare Global Enterprises Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Healthcare Global Enterprises Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Healthcare Global Enterprises Ltd compared to its peers.

Compare the P/E ratios
of Healthcare Global Enterprises Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Healthcare Global Enterprises Ltd with its peers.

Analyze the financial leverage
of Healthcare Global Enterprises Ltd compared to its main competitors.

Show all profitability ratios
for Healthcare Global Enterprises Ltd.

Provide ROE
for Healthcare Global Enterprises Ltd.

Provide ROA
for Healthcare Global Enterprises Ltd.

Provide ROIC
for Healthcare Global Enterprises Ltd.

Provide ROCE
for Healthcare Global Enterprises Ltd.

Provide Gross Margin
for Healthcare Global Enterprises Ltd.

Provide Operating Margin
for Healthcare Global Enterprises Ltd.

Provide Net Margin
for Healthcare Global Enterprises Ltd.

Provide FCF Margin
for Healthcare Global Enterprises Ltd.

Show all solvency ratios
for Healthcare Global Enterprises Ltd.

Provide D/E Ratio
for Healthcare Global Enterprises Ltd.

Provide D/A Ratio
for Healthcare Global Enterprises Ltd.

Provide Interest Coverage Ratio
for Healthcare Global Enterprises Ltd.

Provide Altman Z-Score Ratio
for Healthcare Global Enterprises Ltd.

Provide Quick Ratio
for Healthcare Global Enterprises Ltd.

Provide Current Ratio
for Healthcare Global Enterprises Ltd.

Provide Cash Ratio
for Healthcare Global Enterprises Ltd.

What is the historical Revenue growth
over the last 5 years for Healthcare Global Enterprises Ltd?

What is the historical Net Income growth
over the last 5 years for Healthcare Global Enterprises Ltd?

What is the current Free Cash Flow
of Healthcare Global Enterprises Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Healthcare Global Enterprises Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Healthcare Global Enterprises Ltd

Current Assets 6.8B
Cash & Short-Term Investments 3.1B
Receivables 3B
Other Current Assets 740.3m
Non-Current Assets 20.3B
Long-Term Investments 589.5m
PP&E 15.9B
Intangibles 2.5B
Other Non-Current Assets 1.3B
Current Liabilities 7.4B
Accounts Payable 2.8B
Other Current Liabilities 4.6B
Non-Current Liabilities 11.4B
Long-Term Debt 10.4B
Other Non-Current Liabilities 939m
Efficiency

Earnings Waterfall
Healthcare Global Enterprises Ltd

Revenue
19.7B INR
Cost of Revenue
-9.2B INR
Gross Profit
10.5B INR
Operating Expenses
-8.9B INR
Operating Income
1.6B INR
Other Expenses
-1.1B INR
Net Income
526.1m INR

Free Cash Flow Analysis
Healthcare Global Enterprises Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

HCG Profitability Score
Profitability Due Diligence

Healthcare Global Enterprises Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Positive Free Cash Flow
ROE is Increasing
51/100
Profitability
Score

Healthcare Global Enterprises Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

HCG Solvency Score
Solvency Due Diligence

Healthcare Global Enterprises Ltd's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Average Altman Z-Score
Long-Term Solvency
Average D/E
Short-Term Solvency
37/100
Solvency
Score

Healthcare Global Enterprises Ltd's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HCG Price Targets Summary
Healthcare Global Enterprises Ltd

Wall Street analysts forecast HCG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HCG is 542.47 INR with a low forecast of 439.35 INR and a high forecast of 630 INR.

Lowest
Price Target
439.35 INR
6% Downside
Average
Price Target
542.47 INR
16% Upside
Highest
Price Target
630 INR
35% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for HCG?

Click here to dive deeper.

Dividends

Healthcare Global Enterprises Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for HCG is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

HCG Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Healthcare Global Enterprises Ltd Logo
Healthcare Global Enterprises Ltd

Country

India

Industry

Health Care

Market Cap

65.2B INR

Dividend Yield

0%

Description

HealthCare Global Enterprises Ltd. provides imaging and diagnostics services for cancer treatment. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2016-03-30. The firm is involved retail sale of pharmaceuticals, medical and orthopedic goods and toilet articles. The company operates cancer care network under the HCG brand. The company operates infertility treatment clinics providing assisted reproductive services under brand Milann. The firm operates eight Milann fertility centers, which provide reproductive medicine services, including assisted reproduction, gynecological endoscopy and fertility preservation; and follow a multidisciplinary and technology-focused approach to diagnosis and treatment. Milann fertility centers also offer training programs for fertility specialists and embryologists. Under the Triesta brand, it provides clinical reference laboratory services with specialization in oncology.

Contact

KARNATAKA
Bangalore
Tower Block, Unity Building Complex, No. 3, Mission Road
+918046607700
hcgel.com

IPO

2016-03-30

Employees

5 454

Officers

Executive Chairman
Dr. Basavalinga Sadasivaiah Ajaikumar M.D.
CEO & Whole-Time Director
Mr. Meghraj Arvindrao Gore
Chief Financial Officer
Ms. Ruby Ritolia
President of IT & Chief Information Officer
Mr. Sudeep Dey
Compliance Officer & Company Secretary
Ms. Sunu Manuel Abey
Chief Sales Officer
Mr. Vineesh Kumar Ghei
Show More
Chief Human Resource Officer
Ms. Deepti Gautam Tewari
Executive Director of Strategy & Director
Ms. Anjali Ajaikumar Rossi
Cluster Chief Operating Officer
Manisha Kumar
Chief Supply Chain Officer
Mr. Madan Kumar Sampath
Show Less

See Also

Discover More
What is the Intrinsic Value of one HCG stock?

The intrinsic value of one HCG stock under the Base Case scenario is 492.71 INR.

Is HCG stock undervalued or overvalued?

Compared to the current market price of 468.3 INR, Healthcare Global Enterprises Ltd is Undervalued by 5%.

Back to Top